Adamis Pharma Balance Sheet - Quarterly (NASDAQ:ADMP)

Add to My Stocks
$3.1 $0.05 (1.64%) ADMP stock closing price Sep 21, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Adamis Pharma balance sheet. Financial strength can be guaged by performing Adamis Pharma stock analysis and by analyzing the balance sheet. Quarterly results are typically accompanied with the company releasing financial statements. The balance sheet shows total liabilities of $13.95M and shareholders equity of $25.39M. Adamis Pharma revenue and Adamis Pharma operating cash flow are important in understanding the financial capacity of the company.

View and download Adamis Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Marketable Securities----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets----------
Total Current Assets
Property Plant & Equipment--7.51M-------
Accumulated Depreciation----------
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets------4.93M---
Total Assets
Notes Payable2.48M4.33M---1.53M-1.26M--
Accounts Payable5.16M2.33M2.91M1.75M1.89M2.71M2.15M1.71M4.17M1.5M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses3.45M2.55M3.36M2.47M2.07M1.91M2.07M2.5M2.43M-
Income Taxes Payable----------
Other Current Liabilities---------1.87M
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt2.33M2.45M2.58M2.7M2.82M2.94M3.06M---
Non-Current Capital Leases----------
Other Long-Term Liabilities-------3.18M--
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus156.71M155.06M153.54M152M133.01M115.11M113.74M112.55M96.17M84.12M
Retained Earnings-131.31M-121.61M-113.99M-105.97M-99.2M-94.23M-88.45M-87.78M-81.14M-75.42M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity25.39M33.44M39.54M46.03M33.8M20.87M25.27M24.76M15.03M8.69M
Total Liabilities & Shareholders Equity39.35M43.78M51.4M56.3M43.91M33.69M37.78M36.74M29.36M12.65M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Apart from balance sheet items, an investor would do well to keep track of the Adamis Pharma stock price by looking at Adamis Pharma historical stock prices. One can compare PE with industry average by looking at the Adamis Pharma PE ratio chart. The common balance sheet items are:

  • Assets: ADMP total assets, which was at $39.35M for 2018 Q2 is a balance sheet item representing value of what Adamis Pharma owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Adamis Pharma is $13.95M. Shareholders equity comes under liabilities as it is money the company owes the holders of ADMP stock.

Adamis Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio